Dietary flaxseed independently lowers circulating cholesterol and lowers it beyond the effects of cholesterol-lowering medications alone in patients with peripheral artery disease
- PMID: 25694068
- DOI: 10.3945/jn.114.204594
Dietary flaxseed independently lowers circulating cholesterol and lowers it beyond the effects of cholesterol-lowering medications alone in patients with peripheral artery disease
Abstract
Background: Dietary flaxseed lowers cholesterol in healthy subjects with mild biomarkers of cardiovascular disease (CVD).
Objective: The aim was to investigate the effects of dietary flaxseed on plasma cholesterol in a patient population with clinically significant CVD and in those administered cholesterol-lowering medications (CLMs), primarily statins.
Methods: This double-blind, randomized, placebo-controlled trial examined the effects of a diet supplemented for 12 mo with foods that contained either 30 g of milled flaxseed [milled flaxseed treatment (FX) group; n = 58] or 30 g of whole wheat [placebo (PL) group; n = 52] in a patient population with peripheral artery disease (PAD). Plasma lipids were measured at 0, 1, 6, and 12 mo.
Results: Dietary flaxseed in PAD patients resulted in a 15% reduction in circulating LDL cholesterol as early as 1 mo into the trial (P = 0.05). The concentration in the FX group (2.1 ± 0.10 mmol/L) tended to be less than in the PL group (2.5 ± 0.2 mmol/L) at 6 mo (P = 0.12), but not at 12 mo (P = 0.33). Total cholesterol also tended to be lower in the FX group than in the PL group at 1 mo (11%, P = 0.05) and 6 mo (11%, P = 0.07), but not at 12 mo (P = 0.24). In a subgroup of patients taking flaxseed and CLM (n = 36), LDL-cholesterol concentrations were lowered by 8.5% ± 3.0% compared with baseline after 12 mo. This differed from the PL + CLM subgroup (n = 26), which increased by 3.0% ± 4.4% (P = 0.030) to a final concentration of 2.2 ± 0.1 mmol/L.
Conclusions: Milled flaxseed lowers total and LDL cholesterol in patients with PAD and has additional LDL-cholesterol-lowering capabilities when used in conjunction with CLMs. This trial was registered at clinicaltrials.gov as NCT00781950.
Keywords: cholesterol lowering; flaxseed; peripheral artery disease; platelet aggregation; statins.
© 2015 American Society for Nutrition.
Similar articles
-
A systematic review and meta-analysis of randomized controlled trials of the effect of konjac glucomannan, a viscous soluble fiber, on LDL cholesterol and the new lipid targets non-HDL cholesterol and apolipoprotein B.Am J Clin Nutr. 2017 May;105(5):1239-1247. doi: 10.3945/ajcn.116.142158. Epub 2017 Mar 29. Am J Clin Nutr. 2017. PMID: 28356275 Review.
-
Whole-grain and blood lipid changes in apparently healthy adults: a systematic review and meta-analysis of randomized controlled studies.Am J Clin Nutr. 2015 Sep;102(3):556-72. doi: 10.3945/ajcn.115.109165. Epub 2015 Aug 12. Am J Clin Nutr. 2015. PMID: 26269373 Review.
-
The effect of flaxseed dose on circulating concentrations of alpha-linolenic acid and secoisolariciresinol diglucoside derived enterolignans in young, healthy adults.Eur J Nutr. 2016 Mar;55(2):651-663. doi: 10.1007/s00394-015-0885-2. Epub 2015 Mar 26. Eur J Nutr. 2016. PMID: 25808116 Clinical Trial.
-
Meta-analysis of the effects of flaxseed interventions on blood lipids.Am J Clin Nutr. 2009 Aug;90(2):288-97. doi: 10.3945/ajcn.2009.27469. Epub 2009 Jun 10. Am J Clin Nutr. 2009. PMID: 19515737 Free PMC article.
-
Dietary flaxseed lignan extract lowers plasma cholesterol and glucose concentrations in hypercholesterolaemic subjects.Br J Nutr. 2008 Jun;99(6):1301-9. doi: 10.1017/S0007114507871649. Epub 2007 Dec 6. Br J Nutr. 2008. PMID: 18053310 Clinical Trial.
Cited by
-
Beneficial Effects of Dietary Flaxseed on Non-Alcoholic Fatty Liver Disease.Nutrients. 2024 Feb 6;16(4):466. doi: 10.3390/nu16040466. Nutrients. 2024. PMID: 38398791 Free PMC article.
-
Flaxseed Reduces Cancer Risk by Altering Bioenergetic Pathways in Liver: Connecting SAM Biosynthesis to Cellular Energy.Metabolites. 2023 Aug 14;13(8):945. doi: 10.3390/metabo13080945. Metabolites. 2023. PMID: 37623888 Free PMC article.
-
On the Path towards a "Greener" EU: A Mini Review on Flax (Linum usitatissimum L.) as a Case Study.Plants (Basel). 2023 Mar 1;12(5):1102. doi: 10.3390/plants12051102. Plants (Basel). 2023. PMID: 36903961 Free PMC article. Review.
-
Platelet Aggregation Inhibition: An Evidence-Based Systematic Review on the Role of Herbs for Primary Prevention Based on Randomized Controlled Trials.Iran J Med Sci. 2022 Nov;47(6):505-516. doi: 10.30476/IJMS.2021.91328.2247. Iran J Med Sci. 2022. PMID: 36380973 Free PMC article. Review.
-
Nutraceutical and Pharmaceutical Behavior of Bioactive Compounds of Miracle Oilseeds: An Overview.Foods. 2022 Jun 21;11(13):1824. doi: 10.3390/foods11131824. Foods. 2022. PMID: 35804639 Free PMC article. Review.
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Medical